Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 502

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 502
---
 management does not believe there are any recently issued, but not yet effective, accounting pronouncements, if currently adopted, that would have a material effect on BLAC’s condensed consolidated financial statements. 317 CERTAIN BLAC RELATIONSHIPS AND RELATED PERSON TRANSACTIONS Founder Shares and Private Placement Units On July 30, 2020, BLAC issued an aggregate of 1,437,500 founder shares to the Sponsor for an aggregate purchase price of $25,000 in cash, or approximately $0.014 per share. On April 25, 2022, BLAC executed a stock split, resulting in an aggregate of 1,725,000 founder shares held by the Sponsor (of which up to 225,000shares were subject to forfeiture in the event the underwriter’s Over -AllotmentOption was not exercised in full). At the closing of BLAC’s IPO, the Sponsor transferred 20,000 founder shares to each of Drs. Chung, Reed and Roberts and Mr. Park for their board service and 20,000 placement warrants each to BLAC’s directors who were serving as Chairman of the Board of Directors, Dr. Reed, and the chair of our audit committee, Dr. Chung. On March 23, 2023, BLAC’s Sponsor also transferred 20,000 founder shares and 20,000 placement warrants to Mr. Yoo for his service as Chief Financial Officer. BLAC’s Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per unit, for an aggregate purchase price of $4,300,000, at the closing of BLAC’s IPO. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the founder shares or placement shares, and the placement warrants and placement rights will expire worthless if BLAC does not consummate a business combination by February 14, 2025 (unless such date is extended in accordance with the Existing Governing Documents). The founder shares and the placement units and securities contained therein are each subject to transfer restrictions pursuant to lock -upprovisions in letter agreements with BLAC that were entered into by the Sponsor and BLAC’s officers and directors and, in the case of the founder shares, Continental as escrow agent. Those lock -upprovisions provide that such securities are not transferable or saleable until 36 months after the date of the consummation of BLAC initial business combination, or earlier if, subsequent to BLAC’s